Which has the lower trailing P/E, CI or MRK?

CI has the lower trailing P/E: CI trades at 11.62 and MRK at 115.15. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CI or MRK?

Over the past five years, CI grew revenue faster — CI at a 11.11% CAGR versus MRK at 7.87%.

Does CI or MRK pay a bigger dividend?

CI yields 2.20% and MRK yields 2.32% based on trailing dividends and the latest price.

Is CI or MRK more profitable?

MRK runs the higher net margin — CI at 2.27% versus MRK at 4.78%.

How have CI and MRK total returns compared?

Over the past 10 years, CI delivered 9.30% and MRK delivered 12.68% annualized total return. Past performance doesn't predict future results.

Cigna Corporation (CI) vs Merck & Co., Inc. (MRK)

A side-by-side comparison of Cigna Corporation and Merck & Co., Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.

Cigna Corporation

$74.19B

$280.76HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

MRK

Merck & Co., Inc.

$355.49B

$143.94HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — CI vs MRK

growth of $100 · dividends reinvested · last 10y

CI +144.8% (+9.4%/yr)MRK +228.7% (+12.6%/yr)MRK compounded faster over this window

CI MRK

CI vs MRK: by the numbers

•MRK is the larger company ($355.49B vs $74.19B market cap).
•CI trades at the lower trailing earnings multiple (11.62 vs 115.15 P/E), one valuation lens rather than an overall verdict.
•MRK converts more revenue to profit (4.78% vs 2.27% net margin).
•CI grew revenue faster over the past five years (11.11% vs 7.87% CAGR).
•MRK pays the higher dividend yield (2.32% vs 2.20%).

Metrics side by side

Valuation

Metric	CI	MRK
P/E ratio	11.62	115.15
Forward P/E	9.20	52.41
P/S ratio	0.26	5.35
P/B ratio	1.74	8.48
EV / EBITDA	8.08	22.76
FCF yield	12.28%	4.52%

Profitability

Metric	CI	MRK
Gross margin	11.66%	75.38%
Operating margin	3.46%	36.17%
Net margin	2.27%	4.78%
ROE	15.05%	7.57%
ROIC	7.69%	5.80%

Dividends

Metric	CI	MRK
Dividend yield	2.20%	2.32%
Payout ratio	25.62%	268.80%

Growth (annualized)

Metric	CI	MRK
Revenue CAGR (5Y)	11.11%	7.87%
EPS CAGR (5Y)	-0.76%	21.21%
FCF CAGR (5Y)	-1.95%	23.61%
Total return CAGR (5Y)	8.53%	18.15%

Frequently asked

Which has the lower trailing P/E, CI or MRK?: CI has the lower trailing P/E: CI trades at 11.62 and MRK at 115.15. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CI or MRK?: Over the past five years, CI grew revenue faster — CI at a 11.11% CAGR versus MRK at 7.87%.
Does CI or MRK pay a bigger dividend?: CI yields 2.20% and MRK yields 2.32% based on trailing dividends and the latest price.
Is CI or MRK more profitable?: MRK runs the higher net margin — CI at 2.27% versus MRK at 4.78%.
How have CI and MRK total returns compared?: Over the past 10 years, CI delivered 9.30% and MRK delivered 12.68% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CI analysis Full MRK analysis Interactive comparison tool

Dig into the metrics

Cigna P/E ratio Merck P/E ratio Cigna dividend yield Merck dividend yield Cigna ROE Merck ROE Cigna operating margin Merck operating margin Cigna revenue growth Merck revenue growth Cigna free cash flow Merck free cash flow

Cigna & Merck appear in these rankings

Highest Dividend Yield Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.